1251100

Louise Taber, MD — FEI 3003141724

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)